(Stroke. 1997;28:1730-1732.)
© 1997 American Heart Association, Inc.
Articles |
From the Division of Pathobiology, College of Nursing Art and Science Hyogo, Akashi, Japan.
Correspondence to Osamu Uyama, MD, College of Nursing Art and Science Hyogo, 13-71 Kitaoji-cho, Akashi 673, Japan. E-mail uyama{at}kh.rim.or.jp
| Abstract |
|---|
|
|
|---|
Methods The relation of carotid atherosclerosis to BMD was examined in 30 postmenopausal women aged 67 to 85 years. High-resolution B-mode ultrasonography was performed, and the severity of carotid atherosclerosis was determined by plaque score. BMD was measured by dual-energy x-ray absorptiometry.
Results The correlation of plaque score with low total BMD was r=.549 (P<.002). Multiple linear regression analysis indicated significant correlation of plaque score with total cholesterol level and low total BMD.
Conclusions Our results suggest a relation between carotid atherosclerosis, one of the major causes of ischemic cerebrovascular diseases, and osteoporosis.
Key Words: : atherosclerosis bone density carotid artery diseases osteoporosis ultrasonics
| Introduction |
|---|
|
|
|---|
Extracranial carotid atherosclerosis is one of the major causes of cerebrovascular diseases.3 In our present investigation, we performed high-resolution real-time B-mode ultrasonography to determine the extent of carotid atherosclerosis and quantified the results by use of a scoring system. We then evaluated the relation between osteoporosis and carotid atherosclerosis.
| Subjects and Methods |
|---|
|
|
|---|
Carotid Examination
In all subjects, carotid B-mode imaging was performed
with a 7.5-MHz transducer with an axial resolution of less than
0.4 mm (EUB-555, Hitachi, Japan). The subject was seated
comfortably, and scanning of the extracranial carotid arteries in the
neck was performed bilaterally in three different longitudinal
projections and in the transverse projection. Severity of
carotid atherosclerosis was evaluated by plaque score.
This score, through use of the scoring system method of Handa and
colleagues,3 was computed by summing the maximum thickness
(in millimeters) of the intima-media complex (plaque thickness) of both
sides of the carotid arteries. All ultrasound examinations were
performed by a single sonographer (O.U.), who was blinded to the BMD
readings. The mean coefficient of variation for the difference between
plaque scores obtained in repeated examinations performed by the same
examiner was less than 8%.
Bone Examination
Total BMD, defined as the total BMC divided by the area
(g/cm2), was measured by use of dual-energy x-ray
absorptiometry (XR-26 x-ray bone densitometer, Norland). Lumbar spine
BMD (L2-L4) was also measured.
Statistical Analysis
Data are expressed as mean±SD. The relation between the
plaque score and BMD was evaluated by linear regression
analysis. Multiple linear regression analysis was used
to assess the correlation among BMD, carotid lesion, and risk factors
(age, hypertension, and hypercholesterolemia).
| Results |
|---|
|
|
|---|
|
As shown in the Figure
, there was a
significant linear correlation (r=.549; P<.002)
between plaque score and low total BMD. Lumbar spine BMD was not
significantly associated with plaque score. We also examined the
associations among plaque score, age, hypertension, total
cholesterol, atherogenic index, and total BMD. Multiple
linear regression analysis indicated significant correlation of
plaque score with age, total cholesterol level, and low
total BMD. Hypertension and atherogenic index were not significantly
associated with carotid atherosclerosis in the
postmenopausal women in our study (Table 2
).
|
|
| Discussion |
|---|
|
|
|---|
-OHD3 plus hormones) appear to be useful. Vitamin D
(10 000 to 50 000 IU/d) and 1
-OHD3 (1 to 2
µg/d) resulted in increased bone calcium resorption. The
amount of vitamin D that may increase the incidence of
cardiovascular degeneration was estimated in one
epidemiological study to be 30 µg (1200
IU)/d.6 Fifteen patients in our study had been
treated with 1
-OHD3 (0.25 to 1.0 µg/d). There
were no significant differences in plaque score and total BMD
between the untreated and treated patients (plaque score, 3.38±3.08
versus 3.34±4.59; total BMD, 0.740±0.084 versus 0.739±0.075
g/cm2). Laroche et al7 studied by dual-energy x-ray absorptiometry the BMC of both legs in 18 men presenting with symptomatic arterial disease of the lower limbs. The mean BMC of the leg more severely affected by arterial disease was significantly lower than that of the leg less affected. They suggest that demineralization seems to be related to a direct local effect of atherosclerosis and not to associated general risk factors (eg, tobacco consumption, sedentary lifestyle, lower body-build index). It is tempting to suggest that systemic atherosclerosis is reflected in carotid atherosclerosis and is responsible for osteoporosis.
Broulik and Kapitola8 demonstrated that women with osteoporosis had higher cholesterol levels than control subjects and that BMD in cigarette smokers was significantly lower than in nonsmokers and was not associated with low body weight. Hypercholesterolemia and tobacco consumption are known risk factors for atherosclerosis,3 9 and the link between these risk factors and osteoporosis could well be arterial disease.
Sato et al10 showed that many hemiplegic stroke patients have hypovitaminosis D and osteopenia. A combination of sunlight deprivation due to immobilization (which is caused by cerebral arteriosclerosis) together with decreased dietary intake of vitamin D may be responsible for osteoporosis in subjects with severe carotid atherosclerosis. Our results suggest a relation between osteoporosis and atherosclerosis.
| Selected Abbreviations and Acronyms |
|---|
|
Received February 12, 1997; revision received May 28, 1997; accepted May 28, 1997.
| References |
|---|
|
|
|---|
2. Fujita T, Okamoto Y, Sakagami Y, Ota K, Ohata M. Bone changes and aortic calcification in aging inhabitants of mountain versus seacoast communities in the Kii Peninsula. J Am Geriatr Soc. 1984;32:124-128.[Medline] [Order article via Infotrieve]
3.
Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S,
Fukunaga R, Yoneda S, Kimura K, Kamada T. Ultrasonic evaluation
of early carotid atherosclerosis.
Stroke. 1990;21:1567-1572.
4. Moon J, Bandy B, Davison AJ. Hypothesis: etiology of atherosclerosis and osteoporosis: are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr. 1992;11:567-583.[Abstract]
5. Nordin BE, Horsman A, Crilly RG, Marshall DH, Simpson M. Treatment of spinal osteoporosis in postmenopausal women. Br Med J. 1980;280:451-455.
6. Linden V. Vitamin D and myocardial infarction. Br Med J. 1974;3:647-650.
7. Laroche M, Pouilles JM, Ribot C, Bendayan P, Bernard J, Boccalon H, Mazieres B. Comparison of the bone mineral content of the lower limbs in men with ischaemic atherosclerotic disease. Clin Rheumatol. 1994;13:611-614.[Medline] [Order article via Infotrieve]
8. Broulik PD, Kapitola J. Interrelations between body weight, cigarette smoking and spine mineral density in osteoporotic Czech women. Endocr Regul. 1993;27:57-60.[Medline] [Order article via Infotrieve]
9. Uyama O, Matsui Y, Shimizu S, Michishita H, Sugita M. Risk factors for carotid atherosclerosis and platelet activation. Jpn Circ J. 1994;58:409-515.[Medline] [Order article via Infotrieve]
10.
Sato Y, Maruoka H, Oizumi K, Kikuyama M. Vitamin
D deficiency and osteopenia in the hemiplegic limbs of the stroke
patients. Stroke. 1996;27:2183-2187.
This article has been cited by other articles:
![]() |
P. Hamel, E. Abed, L. Brissette, and R. Moreau Characterization of oxidized low-density lipoprotein-induced hormesis-like effects in osteoblastic cells Am J Physiol Cell Physiol, April 1, 2008; 294(4): C1021 - C1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reddy, J. P. Bilezikian, S. J. Smith, and L. Mosca Reduced Bone Mineral Density Is Associated with Breast Arterial Calcification J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 208 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vega, N. M. Maalouf, and K. Sakhaee The Role of Receptor Activator of Nuclear Factor-{kappa}B (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4514 - 4521. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rzewuska-Lech, M. Jayachandran, L. A. Fitzpatrick, and V. M. Miller Differential effects of 17{beta}-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins Am J Physiol Endocrinol Metab, July 1, 2005; 289(1): E105 - E112. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Schulz, K. Arfai, X. Liu, J. Sayre, and V. Gilsanz Aortic Calcification and the Risk of Osteoporosis and Fractures J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4246 - 4253. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Samelson, D. P. Kiel, K. E. Broe, Y. Zhang, L. A. Cupples, M. T. Hannan, P. W. F. Wilson, D. Levy, S. A. Williams, and V. Vaccarino Metacarpal Cortical Area and Risk of Coronary Heart Disease: The Framingham Study Am. J. Epidemiol., March 15, 2004; 159(6): 589 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Hirose, H. Tomiyama, R. Okazaki, T. Arai, Y. Koji, G. Zaydun, S. Hori, and A. Yamashina Increased Pulse Wave Velocity Associated with Reduced Calcaneal Quantitative Osteo-sono Index: Possible Relationship Between Atherosclerosis and Osteopenia J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2573 - 2578. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, M. Kaji, N. Metoki, K. Satoh, and J. Iwamoto Does compensatory hyperparathyroidism predispose to ischemic stroke? Neurology, February 25, 2003; 60(4): 626 - 629. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Price, H. H. June, J. R. Buckley, and M. K. Williamson SB 242784, a Selective Inhibitor of the Osteoclastic V-H+-ATPase, Inhibits Arterial Calcification in the Rat Circ. Res., September 20, 2002; 91(6): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Price, H. H. June, J. R. Buckley, and M. K. Williamson Osteoprotegerin Inhibits Artery Calcification Induced by Warfarin and by Vitamin D Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Price, S. A. Faus, and M. K. Williamson Bisphosphonates Alendronate and Ibandronate Inhibit Artery Calcification at Doses Comparable to Those That Inhibit Bone Resorption Arterioscler Thromb Vasc Biol, May 1, 2001; 21(5): 817 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. DRAKE, E. SCHADT, K. HANNANI, J. M. KABO, K. KRASS, V. COLINAYO, L. E. GREASER III, J. GOLDIN, and A. J. LUSIS Genetic loci determining bone density in mice with diet-induced atherosclerosis Physiol Genomics, April 27, 2001; 5(4): 205 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Parhami, A. Garfinkel, and L. L. Demer Role of Lipids in Osteoporosis Arterioscler Thromb Vasc Biol, November 1, 2000; 20(11): 2346 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Hak, H. A. P. Pols, A. M. van Hemert, A. Hofman, and J. C. M. Witteman Progression of Aortic Calcification Is Associated With Metacarpal Bone Loss During Menopause : A Population-Based Longitudinal Study Arterioscler Thromb Vasc Biol, August 1, 2000; 20(8): 1926 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ramnemark, M. Nilsson, B. Borssen, and Y. Gustafson Stroke, a Major and Increasing Risk Factor for Femoral Neck Fracture Stroke, July 1, 2000; 31(7): 1572 - 1577. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |